Papers

1

Total Citations

56

H-Index

1

About

Dr. Wenhui Li is a leading clinical researcher in gynecologic oncology, with a primary focus on optimizing surgical treatments for early-stage cervical cancer. Her most cited work addresses a critical controversy in the field: the efficacy of minimally invasive surgery versus open radical hysterectomy. As the lead author of a phase III multicentre randomized controlled trial protocol in China, Dr. Li directly responds to findings from the landmark LACC trial, which suggested poorer outcomes with minimally invasive approaches. Her research aims to provide high-quality evidence on whether different surgical techniques impact clinical and survival outcomes, a question of immense practical importance for surgeons and patients worldwide. With her protocol paper accumulating over 50 citations, Dr. Li’s contributions are shaping the design of rigorous trials that could redefine global treatment standards. Her work exemplifies how thoughtful, methodologically sound research can address urgent clinical dilemmas, ensuring that surgical innovations are matched by robust evidence for safety and efficacy.

Research Focus

Key Achievements

1
H-Index
1
Papers
56
Total Citations
56
Avg Citations/Paper
🏆 Most Cited Paper
Efficacy of different surgical approaches in the clinical and survival outcomes of patients with early-stage cervical cancer: protocol of a phase III multicentre randomised controlled trial in China
56 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago